Skip to main content
    T

    TriSalus Life Sciences Inc. (TLSI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.29
    +0.02 (+1.10%)

    Market Cap: $140.06M

    Last updated: Nov 17, 2026 at 4:26 PM ET

    TriSalus Life Sciences Inc. (TLSI) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    TriSalus Life Sciences (TLSI) trades at 2.9x sales and 198.8x book value. Its P/S ranged from 0.8x in 2023 to 5.8x in 2025 across the 3 year ends with a P/S figure.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales2.9x
    Price to book198.8x
    PEGN/A
    FCF yield-18.4%
    As of Nov 17, 2026

    Valuation History

    Year endPriceP/S
    2025$6.985.8x
    2024$5.014.4x
    2023$8.450.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About TLSI

    What is TLSI's price to sales ratio?

    TriSalus Life Sciences has a price to sales ratio of 2.9x.